1105000I Rev. 02

ALT/GPT BR opt.
REF 1105000 REF 1105010

2 x 50 mL 3 x 100 mL ALT/GPT BR
IFCC
CONTENTS CONTENTS
UV enzymatic method
R1. Reagent 2 x 40 mL R1. Reagent 3 x 80 mL
R2. Reagent 1 x 20 mL R2. Reagent 1 x 60 mL KINETIC
For in vitro diagnostic use only
PRINCIPLE INTERFERENCES
Alanine aminotransferase (ALT/GPT) catalyzes the transfer of the  Lipemia (intralipid 15 g/L) does not interfere.
amino group from alanine to oxoglutarate with the formation of  Bilirubin (>30 mg/dL) does not interfere.
glutamate and pyruvate. The latter is reduced to lactate by lactate  Hemoglobin (>10 g/dL) does not interfere.
dehydrogenase (LDH) in the presence of reduced nicotinamide
adenine dinucleotide (NADH).  Other drugs and substances may interfere3,4.
The reaction is monitored kinetically at 340 nm by the rate of
decrease in absorbance resulting from the oxidation of NADH to
NAD+, proportional to the activity of ALT present in the sample. MATERIALS REQUIRED
ALT/GPT  Photometer or spectrophotometer with a thermostatted cell

L-Alanine + 2-Oxoglutarate L-Glutamate + Pyruvate compartment set at 30/37ºC, capable of reading at 340 nm.
 Stopwatch, strip-chart recorder or printer.
LDH  Cuvettes with 1-cm pathlength.
Pyruvate + NADH + H+ Lactate + NAD+  Pipettes to measure reagent and samples.
This test has been formulated according the standarized method PROCEDURE
described by IFCC. Clin Chem Lab Med 2002; 40(7) : 718-724.
1. Preincubate working reagent, samples and controls to reaction
REAGENT COMPOSITION temperature.
2. Set the photometer to 0 absorbance with distilled water.
R1 ALT substrate. TRIS buffer 150 mmol/L pH 7.3, L-alanine 3. Pipette into a cuvette:
750 mmol/L, lactate dehydrogenase  1350 U/L.
Reaction temperature 37ºC 30ºC
R2 ALT coenzyme. NADH 1.3 mmol/L, 2-oxoglutarate 75
mmol/L. Biocides. Working reagent 1.0 mL 1.0 mL
Sample 50 L 100 L
STORAGE AND STABILITY

4. Mix gently by inversion. Insert cuvette into the cell holder and
start stopwatch.
Store at 2-8ºC. 5. Incubate for 1 minute and record initial absorbance reading.
All the kit compounds are stable until the expiry date stated on the 6. Repeat the absorbance readings exactly after 1, 2 and 3
label. Do not use reagents over the expiration date. minutes.
Store the vials tightly closed, protected from light and prevented 7. Calculate the difference between absorbances.
contaminations during the use. 8. Calculate the mean of the results to obtain the average change
Discard If appear signs of deterioration:
in absorbance per minute (A/min).
- Presence of particles and turbidity.
- Blank absorbance (A) at 340 nm < 1.000 in 1cm cuvette.
CALCULATIONS
REAGENT PREPARATION
U/L = A/min x 3333 (37ºC)
Working reagent. Mix 4 mL of R1 + 1 mL of R2. Stable for 4 weeks U/L = A/min x 1746 (30ºC)
at 2-8ºC.
Protect from light. Samples with A/min exceeding 0.160 at 340 nm should be diluted
1:10 with saline and assayed again. Multiply the results by 10.
SAMPLES If results are to be expressed as SI units apply:
U/L x 0.01667 = kat/L
Serum, EDTA or heparinized plasma free of hemolysis.
ALT is stable in serum or plasma 24 hours at room temperature
and for 1 week at 2-8ºC.
QUALITY SYSTEM CERTIFIED LINEAR CHEMICALS, S.L.U. Joaquim Costa 18 2ª planta. 08390 Montgat (Barcelona) SPAIN
ISO 9001 ISO 13485 Telf. (+34) 934 694 990; E-mail: info@linear.es ; website: www.linear.es NIF-VAT:B60485687
REFERENCE VALUES4 NOTES
Serum, plasma 1. This method may be used with different instruments. Any
application to an instrument should be validated to demonstrate
37ºC up to 40 U/L (0.67 kat/L) that results meets the performance characteristics of the
Adults method. It is recommended to validate periodically the
30ºC up to 25 U/L (0.42 kat/L) instrument. Contact to the distributor for any question on the
application method.
Levels approximately twice the adult level are seen in neonates and 2. Clinical diagnosis should not be made on findings of a single test
infants; these decline to adult level by approximately 6 months of age. result, but should integrate both clinical and laboratory data.
It is recommended that each laboratory establishes its own
reference range.
REFERENCES
QUALITY CONTROL
1. Winn-Deen E S, David H, Sigler G, and Chavez R. Clin Chem
To ensure adequate quality control (QC), each run should include a 1988;34:2005.
set of controls (normal and abnormal) with assayed values handled 2. International Federation of Clinical Chemistry (IFCC). Clin
as unknowns. Chem Lab Med 1998;36:185.
REF 1980005 HUMAN MULTISERA NORMAL 3. Young DS. Effects of drugs on clinical laboratory tests, 5th
Borderline level of ALT. Assayed. ed. AACC Press, 2000.
4. Tietz. Textbook of Clinical Chemistr, 2rnd Edition. Burtis CA,
REF 1985005 HUMAN MULTISERA ABNORMAL Ashwood ER. W.B. Saunders Co. 1994.
Elevated level of ALT. Assayed.
If the values are found outside of the defined range, check the
instrument, reagents and procedure.
Each laboratory should establish its own Quality Control scheme
and corrective actions if controls do not meet the acceptable
tolerances.
CLINICAL SIGNIFICANCE
The group of enzymes called transaminase exist in tissues of many

organs. Necrotic activity in these organs causes a release of
abnormal quantities of enzyme into the blood where they are
measured.
Since heart tissue is rich in AST increased serum levels appear in
patients after myocardial infarction, as well as in patients with
muscle disease, muscular dystrophy and dermatomyositis.
The liver is specially rich in ALT, being the enzyme measurement
used primarily as a test for infectious and toxic hepatitis, although
high levels of both ALT and AST may also be found in cases of liver
cell damage and acute pancreatitis, suggesting that the obstruction
of the biliary tree by the edematous pancreas and the presence of
associate hepatic disease may contribute to elevated AST levels in
these patients.
Slight or moderate elevations of AST and ALT activities may be
observed after intake of alcohol and after administration of various
drugs, such as salicylates, opiates and ampicillin.
ANALYTICAL PERFORMANCE
- Detection Limit : 7.95 U/L

- Linearity : Up to 500 U/L
- Precision:
U/L Within-run Between-run
Mean 32.4 140.8 32.4 140.8
SD 0.79 1.41 0.97 2.77
CV% 2.43 1.00 3.49 1.97
N 10 10 10 10
- Sensitivity : 0.280 mA / min/ U/L GPT.

- Correlation: This assay (y) was compared with a similar commercial
method (x). The results were:
N = 50 r = 0.99 y = 1.041x + 1.447
The analytical performances have been generated using on

automatic instrument. Results may vary depending on the
instrument. B1105-2/0901
QUALITY SYSTEM CERTIFIED R1.ing
LINEAR CHEMICALS, S.L.U. Joaquim Costa 18 2ª planta. 08390 Montgat (Barcelona) SPAIN
ISO 9001 ISO 13485 Telf. (+34) 934 694 990; E-mail: info@linear.es ; website: www.linear.es NIF-VAT:B60485687

1105000I Rev. 02

Uploaded by

Copyright:

Available Formats

1105000I Rev. 02

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

1105000I Rev. 02

Uploaded by

Copyright:

Available Formats

ALT/GPT BR opt.

REF 1105000 REF 1105010

ALT/GPT  Photometer or spectrophotometer with a thermostatted cell

STORAGE AND STABILITY

The group of enzymes called transaminase exist in tissues of many

- Detection Limit : 7.95 U/L

- Sensitivity : 0.280 mA / min/ U/L GPT.

The analytical performances have been generated using on

You might also like

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.